Nearly 20 million Americans suffer from chronic, debilitating pain, reports the Centers for Disease Control and Prevention. Nearly half of them have relied on opioids for long-term pain management.
Restrictions on access to these drugs over the last decade — reduced dosages, shortened prescriptions or cutting patients off entirely — have consigned possibly millions to a life of intense pain. It has driven some to suicide, and others to illicit street drugs like heroin, leading to fatal overdoses.
Newly released CDC guidelines on opioid prescribing should lead to more flexible policies that enable the nation to battle a horrific and deadly epidemic of opioid addiction, while allowing pain patients to get the medications they legitimately need.
Efforts to reduce opioid prescribing, starting after 2000, are a natural reaction to a still-worsening epidemic of addiction created largely by opioid painkillers that flooded the market in the 1990s and later. Many primary care physicians were overprescribing painkillers like OxyContin, with little knowledge of their addictive properties.
By 2016, when the previous CDC guidelines on prescribing opioids were issued, many patients functioning well on daily doses of opioids were forced off by doctors, health systems or insurance providers who misinterpreted those guidelines to mean opioids should effectively be banned from long-term pain management. Some doctors refused to take new patients who needed opioid medications, fearing they could lose their licenses or be charged criminally.
The backlash against the use of opioids for pain management was understandable. Deaths from drug overdoses now exceed 100,000 a year. including more than 5,000 annually in Pennsylvania. Allegheny County alone reported 719 overdose deaths in 2021. Here and around the country, the vast majority of those deaths are opioid-related.
The growing number of fatal overdoses, however, are no longer driven by prescribing policies, but the growing presence of illegally manufactured fentanyl in U.S. street drugs. A synthetic opioid, fentanyl is up to 50 times stronger than heroin, and 100 times stronger than morphine.
Overdose deaths, which have risen after COVID, will continue to rise unless the growth of fentanyl in street drugs is stopped. Other underlying causes include poor access to addiction treatment, including Medication Assisted Treatment, and inadequate health care coverage. Only a fraction of the patients with Opioid Use Disorder receive effective treatment medications such as Suboxone and methadone.
Cutting off pain medication for people with legitimate needs will have little, in any, effect on the current epidemic of addiction. If fact, it could worsen the crisis by driving people to illicit street drugs.
The pendulum on opioid access, from the late 1990s to today, has swung too far in the other direction. New voluntary clinical recommendations from the CDC at least suggest more flexible, patient-centered policies. They stress the importance not only of non-opioid alternatives for managing pain, but also of doctors and patients having the autonomy to make informed decisions on opioid use.
How much updated CDC guidelines on opioids will help will depend largely on how they are interpreted. In most ways, CDC guidelines have changed little and may have even become more stringent.
At minimum, however, they are explicit in not intending to stop opioid use, when the benefits to patients outweigh any potential risks in treating chronic or acute pain. They acknowledge that discontinuing opioid use, or rapidly tapering off it, can harm patients.
These caveats may be no more than tweaks, or lip service to patient-physician autonomy, as some critics have said. Still, they can change, significantly, how opioids are prescribed. Primary care physicians, state medical boards, hospitals, pharmacies, insurance companies, health systems, regulatory agencies, state legislators and law enforcement should interpret them broadly and literally: Flexible, patient-centered policies should replace rigid one-size-fits-all practices. The CDC also has recognized the role of medical cannabis in managing and treating pain.
Lawsuits against the pharmaceutical manufacturers that misled doctors, pharmacies and the public during the 1990s about the addictive properties of opioids like OxyContin have collected billions of dollars that state and local governments will use to stem the tide of addiction. They should use that money for evidence-based treatment and prevention programs.
Meantime, people who suffer from chronic and acute pain should be able to get the medications they need to live happy and productive lives. The updated voluntary CDC guidelines can help if those responsible for delivering pain medications take recommendations for more flexible prescribing policies to heart.




Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.